Kestra Medical Technologies (KMTS) Cash from Investing Activities (2024 - 2026)
Kestra Medical Technologies (KMTS) has disclosed Cash from Investing Activities for 3 consecutive years, with -$14.9 million as the latest value for Q1 2026.
- Quarterly Cash from Investing Activities fell 235.26% to -$14.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$38.0 million through Jan 2026, down 89.28% year-over-year, with the annual reading at -$23.3 million for FY2025, 90.6% down from the prior year.
- Cash from Investing Activities for Q1 2026 was -$14.9 million at Kestra Medical Technologies, down from -$7.4 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$4.2 million in Q2 2024, with the low at -$14.9 million in Q1 2026.
- Average Cash from Investing Activities over 3 years is -$7.3 million, with a median of -$7.2 million recorded in 2024.
- The sharpest move saw Cash from Investing Activities fell 17.03% in 2025, then crashed 235.26% in 2026.
- Over 3 years, Cash from Investing Activities stood at -$4.4 million in 2024, then tumbled by 67.87% to -$7.4 million in 2025, then plummeted by 101.06% to -$14.9 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$14.9 million, -$7.4 million, and -$8.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.